Hints and tips:
...Amgen has reached an agreement with the US antitrust regulator that allows the drugmaker to press ahead with its $28bn acquisition of Horizon Therapeutics....
...Another sign of hardening attitudes was the FTC’s attempt last month to block Amgen’s $28.3bn takeover of Horizon Therapeutics, despite the two businesses treating different diseases....
...The Regeneron chief executive has backed an attempt by US regulators to block Amgen’s $28bn acquisition of Horizon Therapeutics as he accused some pharmaceutical companies of abusing their market power to...
...Therapeutics....
...Therapeutics and Microsoft’s $75bn purchase of game developer Activision Blizzard....
...Therapeutics to proceed....
...The FTC attempted to block Amgen’s $28.3bn takeover of Horizon Therapeutics. Barriers to M&A are going to make it harder for pharma companies to replenish drug pipelines....
...In December, biopharmaceutical firm Amgen announced the acquisition of biotech star Horizon Therapeutics for $116.50 per share or $28bn in aggregate....
...His comments came after the US Federal Trade Commission on Tuesday sued to block Amgen’s $28bn takeover of Horizon Therapeutics....
...The Federal Trade Commission sued to block the biotechnology company Amgen’s $28.3bn deal to acquire Horizon Therapeutics, Italy is struggling to spend €200bn in EU Covid recovery funds, and Ukraine said...
...Amgen is close to a deal to acquire Horizon Therapeutics in a transaction worth as much as $20bn, according to sources familiar with the matter, as a sell-off in healthcare stocks creates attractive targets...
...Amgen has agreed to buy Horizon Therapeutics for $28.3bn, including debt, after the California-based biotech won a three-way race to secure a new pipeline of drugs for rare autoimmune and inflammatory diseases...
...Late last year, Amgen bought Horizon Therapeutics for $28bn. Biotech and life science valuations have moderated since 2021. But the chance for premium buyouts has not disappeared....
...As the EU approved Microsoft’s $75bn bid to buy Activision Blizzard, the US Federal Trade Commission sued to block Amgen’s $28.3bn deal to acquire Horizon Therapeutics and warned of “rampant consolidation...
...The company is buying Ireland-based drugmaker Horizon Therapeutics for more than $28bn, including debt....
...Therapeutics and Pfizer’s $43bn acquisition of Seagen, a specialist in drugs to treat tumours....
...The deal follows Amgen’s $28.3bn acquisition of the Californian biotech Horizon Therapeutics in December. In 2023, Seagen expects revenue of about $2.2bn, a 12 per cent rise year on year....
...It’s litigating an order for Illumina to divest cancer screening company Grail in a vertical merger case and has also sued to block Amgen’s $28bn takeover of Horizon Therapeutics....
...The Federal Trade Commission’s decision on Tuesday to file a lawsuit to block Amgen’s $28.3bn deal to acquire Horizon Therapeutics was unexpected as most of the people involved didn’t think there was an...
...Looming over the horizon is the holiday weekend in late February that typically marks the beginning of the US spring break travel season....
...It is not all sunny skies, however, with geopolitics and local US issues both clouding the horizon....
...Therapeutics, since December....
...What else is on the horizon for you? Inclusivity. Embracing people of all different backgrounds regardless of race, colour, creed, size. Our Adaptive line [for children with disabilities]....
...Campari will be hard hit by COVID-19 due to high On Trade exposure, especially in core markets of Italy and the USA....
...Its multiple sclerosis treatment Tecfidera now has a rival from Genentech, and a muscular dystrophy drug Spinraza is expected soon to have a new rival from PTC Therapeutics....
International Edition